New Marketplace

Innovative Mergers Will Disrupt Health Care

Infographic · February 16, 2018

Disruption of Innovative Mergers in Health Care Industry - BDO graphic

  Click To Enlarge.

Health care players are crossing traditional boundaries — and health care providers expect recent combinations to overturn the industry. In light of recent mergers such as CVS-Aetna and Optum-DaVita, we conducted an NEJM Catalyst Buzz Survey, sponsored by BDO, to ask the NEJM Catalyst Insights Council what impact they expect from innovative mergers and potential new entrants. By a large majority, members of the Insights Council, a qualified group of U.S. executives, clinical leaders, and clinicians involved in health care delivery, expect these mergers to disrupt the prevailing order over the next 3 years. They expect the greatest impact from the CVS-Aetna deal (if approved), followed by Amazon entering the fray. (This survey was conducted just before Amazon, JPMorgan Chase, and Berkshire Hathaway said they would form an independent health care company, which sent shock waves throughout health care and the stock market.) Google and Apple are also expected to have a significant disruptive influence, though neither company has specified its plans for the health care industry.

New call for submissions ­to NEJM Catalyst

Now inviting longform articles

Connect

A weekly email newsletter featuring the latest actionable ideas and practical innovations from NEJM Catalyst.

Learn More »

More From New Marketplace
Comparison of Certain Model Features in Blue Cross NC Blue Premier vs Next-Generation ACO Model vs BCBSMA Alternative Quality Contract

Engineering a Rapid Shift to Value-Based Payment in North Carolina: Goals and Challenges for a Commercial ACO Program

We believe North Carolina can be a model for the nation.

Small Molecule Drugs Facing Generic Competition - Orphan and Non-Orphan Drugs - Orphan Drug Act

It’s Time to Reform the Orphan Drug Act

Three proposals for improving the law to reflect 21st-century drug development practices.

Three-Part Pricing of PCSK9 Inhibitors

A New Model for Pricing Drugs of Uncertain Efficacy

Are we paying too much for new drugs before we know how well they work? This innovative pricing model proposes postponing major rewards until efficacy is established — which could help both patients and payers while still paying back investments on the most effective drugs.

what does quality measurement in health care mean

Buzz Survey Report: Addressing the Problems of Quality Measurement

An independent NEJM Catalyst report sponsored by University of Utah Health on patient involvement in quality measurement.

Average HOOS and Average KOOS for patients undergoing hip and knee replacement at CJRI

Building a “Hospital-within-Hospital” Model for Joint Replacements

The Connecticut Joint Replacement Institute has demonstrated that formerly competing independent providers can unite on a common vision to yield drastic improvements in quality, safety, and costs.

Discharge Rates and Follow-Up Internval Dashboard for One Provider at MGH Dermatology

A Successful Pilot to Improve Access by Adjusting Discharge and Follow-Up Rates

Actionable data and modest financial incentives can help motivate clinicians to adjust their behavior around scheduling follow-up appointments.

Cautious Optimism That Value-Based Reimbursement Will Become Primary Revenue Model

Survey Snapshot: What Would Accelerate the Adoption of Value-Based Care?

NEJM Catalyst Insights Council members weigh in on the barriers and path forward to value-based health care.

Strongwater08_pullquote primary care value proposition and disruptive innovation

The Evolution of Primary Care: Embracing Innovation While Protecting the Core Value

Primary care must leverage disruptive innovations to ensure that patients receive first-access, comprehensive, coordinated, continuous care that is woven into a seamlessly integrated system.

Berns01_pullquote nephrologists dialysis facility joint venture conflicts of interest

Dialysis-Facility Joint-Venture Ownership — Hidden Conflicts of Interest

Despite potential benefits, joint ventures between nephrologists and dialysis companies raise legal and ethical concerns because of participants’ conflicts of interest and lack of transparency.

Fee-for-Service Continues to Account for the Majority of Revenue

New Marketplace Survey: Transitioning Payment Models: Fee-for-Service to Value-Based Care

In a survey of the NEJM Catalyst Insights Council sponsored by Optum, respondents express enthusiasm for value-based care but have conflicting opinions about just how far along that path they should go.

Connect

A weekly email newsletter featuring the latest actionable ideas and practical innovations from NEJM Catalyst.

Learn More »

Topics

Engineering a Rapid Shift to Value-Based…

We believe North Carolina can be a model for the nation.

Engineering a Rapid Shift to Value-Based…

We believe North Carolina can be a model for the nation.

Bundled Payments

59 Articles

Building a “Hospital-within-Hospital” Model for Joint…

The Connecticut Joint Replacement Institute has demonstrated that formerly competing independent providers can unite on…

Insights Council

Have a voice. Join other health care leaders effecting change, shaping tomorrow.

Apply Now